SRZN · Surrozen, Inc. · Executive Compensation
$28.46
-2.21 (-7.21%)
At close · Nov 20
Return incl. dividend (before tax)
Q4 2022 earnings call transcript
Market Cap
$542.49M
Shares
19.06M
Volume · Nov 20
148.86K
Avg daily vol (3M)
531.32K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Craig Parker | President and Chief Executive Officer | $2,819,017 |
| Charles Williams | Chief Operating Officer and Corporate Secretary | $1,518,919 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Craig Parker | President and Chief Executive Officer | $1,520,085 |
| Charles Williams | Chief Financial Officer, Chief Operating Officer and Corporate Secretary | $1,007,326 |
| Yang Li | Executive Vice President, Research | $847,193 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Craig Parker | President and Chief Executive Officer | $1,165,250 |
| Wen-Chen Yeh | M.D., Ph.D. Former Chief Scientific Officer | $716,294 |
| Charles Williams | Chief Financial Officer, Chief Operating Officer and Corporate Secretary | $675,526 |
| Yang Li | Executive Vice President, Research | $576,732 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Craig Parker | President and Chief Executive Officer | $1,895,450 |
| Charles Williams | Chief Financial Officer, Chief Operating Officer and Corporate Secretary | $904,215 |
| Wen-Chen Yeh | M.D., Ph.D. Former Chief Scientific Officer | $867,493 |
| Yang Li | Executive Vice President, Research | $662,960 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Craig Parker | President and Chief Executive Officer | $4,212,626 |
| Wen-Chen Yeh | M.D., Ph.D. Chief Scientific Officer | $744,073 |
| Charles Williams | Chief Financial Officer | $635,236 |
| Gad Soffer | Former Chief Executive Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Charles Williams | Chief Financial Officer | $581,293 |
| Craig Parker | President and Chief Executive Officer | $553,500 |
| Wen-Chen Yeh | M.D., Ph.D. Chief Scientific Officer | $497,560 |
| Gad Soffer | Former Chief Executive Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
|
Shao-Lee Lin, M.D., Ph.D.
“Dr. Lin’s resignation was not because of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
|
Board of Directors | Resigned | 2026-01-30 |
| Andrew Maleki | Chief Financial Officer | Appointed | 2025-11-07 |
| Tim Kutzkey | Class I director | Appointed | 2025-03-28 |
|
Tim Kutzkey, Ph.D.
“Dr. Kutzkey's resignation is not the result of any disagreement with us on any matter relating to our operations, policies or practices.”
|
member of our board of directors | Resigned | 2024-07-01 |
| Charles Williams | Chief Operating Officer | Appointed | 2024-02-07 |
| Wen-Chen Yeh, M.D., Ph.D. | Scientific Advisory Board | Appointed | 2023-07-19 |
| Eric Bjerkholt | Class I director | Appointed | 2023-04-05 |
| Tim Kutzkey, Ph.D. | Chair of the Board | Appointed | 2021-08-17 |
| Christopher Y. Chai | Board | Appointed | 2021-08-17 |
| Mace Rothenberg, M.D. | Board | Appointed | 2021-08-17 |
| David J. Woodhouse, Ph.D. | Board | Appointed | 2021-08-17 |
| Mary Haak-Frendscho, Ph.D. | Board | Appointed | 2021-08-17 |
| Shao-Lee Lin, M.D., Ph.D. | Board | Appointed | 2021-08-17 |
| Tim Kutzkey, Ph.D. | Board | Appointed | 2021-08-17 |
| Anna Berkenblit, M.D. | Board | Appointed | 2021-08-17 |
| Craig Parker | Board | Appointed | 2021-08-17 |
Leadership
- Gad Soffer CEO
- Tim Kutzkey Chairman
- Tim Kutzkey, Ph.D. Chairman, Board Member
- Andrew Maleki CFO
- Charles Williams COO
- Anna Berkenblit Board Member
- Anna Berkenblit, M.D. Board Member
- Christopher Y. Chai Board Member
- Craig Parker Board Member
- David J. Woodhouse Board Member
- David J. Woodhouse, Ph.D. Board Member
- Eric Bjerkholt Board Member
- Mace Rothenberg Board Member
- Mace Rothenberg, M.D. Board Member
- Mary Haak-Frendscho Board Member
- Mary Haak-Frendscho, Ph.D. Board Member
- Shao-Lee Lin, M.D., Ph.D. Board Member
Key facts
CIK
1824893
CUSIP
86889P208
13F (30d)
97 filings
93 filers
Visit website
Investor relations